Last updated: August 17, 2026
Mesenchymal stem cells (MSCs), a type of multipotent stromal cell, have garnered significant attention in regenerative medicine due to their remarkable therapeutic potential. This article provides a comprehensive analysis of MSCs, exploring their historical significance, characteristics, differentiation capabilities, therapeutic applications, and future directions.
Historical Overview and Discovery of MSCs
MSCs were first identified in 1991 by Friedenstein et al. from bone marrow aspirates. Initially termed "colony-forming unit-fibroblasts," these cells exhibited the ability to differentiate into adipocytes, chondrocytes, and osteoblasts, sparking interest in their regenerative potential. Subsequent research confirmed the presence of MSCs in various tissues, including adipose tissue, umbilical cord blood, and synovial fluid.
Characteristics and Phenotype of Mesenchymal Stem Cells
MSCs are characterized by their spindle-shaped morphology and adherence to plastic surfaces. They express a unique set of surface markers, including CD73, CD90, and CD105, while lacking hematopoietic markers such as CD34 and CD45. MSCs also possess a high proliferative capacity and can be expanded in vitro for therapeutic use.
Multipotency and Differentiation Potential of MSCs
MSCs exhibit multipotency, meaning they can differentiate into various cell lineages. Under appropriate culture conditions, they can give rise to mesodermal lineages, including osteoblasts, chondrocytes, and adipocytes. Additionally, MSCs have demonstrated the potential to differentiate into ectodermal and endodermal lineages, although this is less well-established.
Therapeutic Applications of Mesenchymal Stem Cells
MSCs hold promise for a wide range of therapeutic applications. Their ability to differentiate into multiple cell types, secrete growth factors, and modulate immune responses has made them a potential treatment for various diseases and conditions, including bone defects, cartilage injuries, immune disorders, and cardiovascular diseases. Clinical trials are ongoing to evaluate the safety and efficacy of MSC-based therapies in these areas.
Scientific Case Review
Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?
Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.
- Review of the information you provide
- Relevant research and clinical program information
- A clear response focused on your situation
No obligation. Your question will be reviewed confidentially.
Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.
